{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-26-000080","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2026-08-05T20:06:08+00:00","discovered_at":"2026-08-05T20:08:00.245896+00:00","generated_at":"2026-08-05T20:09:27.355733+00:00","sec_items":["2.02","2.05","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Emergent BioSolutions Q2 revenue up 66% to $234M, net loss $180M on $191M impairment; restructuring cuts 93 jobs","bullets":["Q2 total revenues $234.3M (+66% YoY); adjusted net income $30.9M (+134% YoY); GAAP net loss $180.2M due to $191.3M non-cash impairment on NARCAN asset group.","Restructuring plan: cut ~93 employees, close Gaithersburg wet labs; expected annualized savings ~$40M, charges $10M-$11.5M in H2 2026.","Simon Lowry (CMO, Head of R&D) departing Aug 19; Stephanie Duatschek named EVP, Chief Growth Officer.","Naloxone revenue down 22% to $52.4M; Smallpox MCM up 150% to $101.6M; Other Products (BAT) up to $54.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-26-000080","json":"https://secwatch.observer/filing/0001367644-26-000080.json","markdown":"https://secwatch.observer/filing/0001367644-26-000080.md","text":"https://secwatch.observer/filing/0001367644-26-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764426000080/0001367644-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764426000080/ebs-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:09:27.355733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}